Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Article :100632

    
• • ·Content

    Article :100633

    

• Editorial

  • ·Eligibility of men vs. women in Alzheimer’s trials: Inclusive vs. representative

    Article :100625

    Joshua D. Grill, Daniel L. Gillen

    Plan Plan

• Original article

  • ·Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohort

    Article :100580

    Lieza G. Exalto, Siti S. Syaziyah, Xiaotian T Fang, Niels D. Prins, Sietske A.M. Sikkes, Wiesje M. van der Flier, Everard G.B. Vijverberg, Yvonne M.F. Lim

    Résumé Résumé Plan Plan   

• Editorial

  • ·Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies

    Article :100626

    Elizabeth Anne Breen

    Résumé Résumé Plan Plan

• Review

  • ·RNA-based therapeutics for Alzheimer’s disease and related tauopathies: challenges and opportunities

    Article :100585

    Binita Rajbanshi, Ilaria Brentari, Michela Alessandra Denti, Jeffrey L. Cummings, Anuj Guruacharya

    Résumé Résumé Plan Plan  

• Editorial

  • ·Time to pay attention to sleep for Alzheimer’s disease in women

    Article :100624

    Ece Bayram

    Plan Plan

• Original articles

  • ·Sleep complaints and genetic risk of Alzheimer’s disease in older women: associations with memory and tau deposition

    Article :100581

    Kitty K Lui, Xin Wang, Melanie A Dratva, Ella T. Lifset, Jordan Stiver, Nadine C. Heyworth, Qian Shen, Michael Thomas, Pamela N. DeYoung, Atul Malhotra, Erin E. Sundermann, Sarah J. Banks

    Résumé Résumé Plan Plan   
  • ·Tetanus, diphtheria and pertussis vaccination and risk for incident dementia among adults with down syndrome

    Article :100583

    Kimberly Schiel, Joanne Salas, Anjani Urban, Daniel F. Hoft, Jeffrey F. Scherrer

    Résumé Résumé Plan Plan   

• Brief report

  • ·Epigenetic aging and blood based neurodegeneration markers in LASI-DAD

    Article :100595

    Jung Ki Kim, Thalida E. Arpawong, Bharat Thyagarajan, Jennifer A. Smith, Sithara Vivek, Scott Ratliff, Sharmistha Dey, Jinkook Lee, Eileen M. Crimmins

    Résumé Résumé Plan Plan   

• Original articles

  • ·Hypertension acts together with Aβ pathology in late-life to promote memory loss

    Article :100579

    Lucas U Da Ros, João Pedro Ferrari-Souza, Marco Antônio de Bastiani, Lucas A. Hauschild, Bruna Bellaver, Pamela C.L. Ferreira, Douglas Teixeira Leffa, Guilherme Povala, Firoza Z. Lussier, Mira Chamoun, Gleb Bezgin, Andrea L. Benedet, Nesrine Rahmouni, Arthur C. Macedo, Kaj Blennow, Nicholas Ashton, Henrik Zetterberg, Wyllians Vendramini Borelli, Diogo O. Souza, Tharick A. Pascoal, Pedro Rosa-Neto, Eduardo R. Zimmer, Alzheimer’s Disease Neuroimaging Initiative

    Résumé Résumé Plan Plan   
  • ·Interaction of diet and physical activity on dementia risk: the Rotterdam study

    Article :100594

    Muhammed Lamin Sambou, M. Arfan Ikram, M. Kamran Ikram, Jeremy A. Labrecque, Frank J. Wolters

    Résumé Résumé Plan Plan   
  • ·Neuropsychiatric symptoms and dementia development: a 15-year population-based study

    Article :100596

    Francesca Remelli, Giulia Grande, Serhiy Dekhtyar, Erika J Laukka, Caterina Trevisan, Stefano Volpato, Laura Fratiglioni, Federico Triolo

    Résumé Résumé Plan Plan   
  • ·Plasma brain-derived p-Tau217 outperforms other p-Tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burden

    Article :100615

    Joyce R. Chong, Saima Hilal, Narayanaswamy Venketasubramanian, Michael Schöll, Nicholas J. Ashton, Henrik Zetterberg, Christopher P. Chen, Mitchell K.P. Lai

    Résumé Résumé Plan Plan   

• Short communication

  • ·Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC

    Article :100598

    Kristian Steen Frederiksen, Mercè Boada, Lutz Frölich, Milica Kramberger, Nikolaos Scarmeas, Everard Vijverberg, Pieter Jelle Visser, Gunhild Waldemar, Eric Westman, Henrik Zetterberg, Sebastiaan Engelborghs, Frank Jessen

    Plan Plan

• Original articles

  • ·Reductions in neuropsychiatric symptoms after lecanemab treatment and their associations with imaging markers of β-amyloid clearance

    Article :100600

    Yaping Yan, Daoyan Hu, Linlin Kong, Kaicheng Li, Jun Su, Yingzhe Wu, Hongwei Zhan, Hong Zhang, Yidan Sun, Xiaofeng Dou, Peiyu Huang, Jiong Zhou

    Résumé Résumé Plan Plan   
  • ·Adapting the spanish healthcare system for disease-modifying treatments in early-stage alzheimer’s disease

    Article :100586

    R. Sánchez Valle, A. Lleó Bisa, A. Villarejo Galende, E. Cuartero Rodríguez, J. Escudero-Torrella, N. Bargallo Alabart

    Résumé Résumé Plan Plan   
  • ·Diagnostic performance of an automated plasma p-tau217 chemiluminescent assay for detecting Aβ pathology in a Chinese memory clinic cohort

    Article :100613

    Shuai Chen, Feng-Yu Wang, Rong Li, Chang Fu, Jing-Yu Shao, Yu Shen, Kai Ma, Xiao-Di Hao, Lin Cao, Jun-Ling Xu, Jie-Wen Zhang

    Résumé Résumé Plan Plan   
  • ·Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer’s disease

    Article :100612

    David López-Martos, Raffaele Cacciaglia, Marc Suárez-Calvet, Gemma Salvadó, Mahnaz Shekari, Armand González-Escalante, Marta Milà-Alomà, Anna Brugulat-Serrat, Carolina Minguillon, Matteo Tonietto, Edilio Borroni, Gregory Klein, Clara Quijano-Rubio, Gwendlyn Kollmorgen, Henrik Zetterberg, Kaj Blennow, Juan Domingo Gispert, Oriol Grau-Rivera, Gonzalo Sánchez-Benavides, ALFA study

    Résumé Résumé Plan Plan   

• Review

  • ·Biomarkers in preclinical and early Alzheimer’s disease in China: a scoping review

    Article :100599

    Guoping Peng, Yan Yang, Ying Wang, Sagar Anil Chandekar, Jintai Yu

    Résumé Résumé Plan Plan   

• Original article

  • ·Association between obstructive sleep apnea severity and glymphatic-related DTI-ALPS alterations in newly diagnosed, Drug-Naïve Alzheimer’s disease

    Article :100597

    Wenxue Zheng, Yao Zhou, Yurui Xia, Yiqing Wang

    Résumé Résumé Plan Plan   

• Review

  • ·Virtual reality-based training in patients with alzheimer's disease: A systematic review and meta-analysis

    Article :100590

    Junjie Wang, Can Wu, Kedong Zhu, Xiaoshan Qi, Guiqin Chen

    Résumé Résumé Plan Plan  

• Original article

  • ·Phenotyping of mild behavioral impairment domains in multi-regional dementia-free older adults of Chinese ethnicity: impulse dyscontrol as the leading domain

    Article :100589

    Yingqi Liao, Yaping Zhang, Haoran Zhang, Yan Li, Dylan X. Guan, Yifan Yan, Yuek Ling Chai, Mitchell K.P. Lai, Shifu Xiao, Christopher L.H. Chen, Xin Xu

    Résumé Résumé Plan Plan   

• Special article

  • ·Income, diet, and cognitive function: observational analyses and candidate metabolomic pathways identified by Mendelian randomization

    Article :100582

    Xingguang Zhao, Weijian Wu, Qiaoxuan Zhang, Mengqian Ouyang, Haoyu Luo, Qun Yu, Yingren Mai, Zhiyu Cao, Shaoqing Yang, Mingsong Xu, Jun Liu, Wang Liao

    Résumé Résumé Plan Plan   

• Original article

  • ·The growing burden of dementia in Asia: Comparative insights from Japan, China, and India

    Article :100614

    Chen Zhang, Xuhui Chen, Yongan Sun

    Résumé Résumé Plan Plan   

• Letters to the editor

  • ·Asia’s dementia burden: from epidemiological description to prevention-oriented neurology

    Article :100627

    Haoyang Hu

    Plan Plan
  • ·Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE₄ heterozygotes and non-carriers

    Article :100587

    Jemma Hazan, Kathy Y. Liu, Robert Howard

    Plan Plan
  • ·Hazan J; Liu KY; Howard R. Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers. # TJPAD-D-26-00165

    Article :100588

    Lutz Froelich

    Plan Plan

• 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference, December 1-4, 2025, San Diego, CA (United States) - Conference proceedings

  • ·Welcome to CTAD25 in San Diego!

    Article :100616

    Paul Aisen

    
  • ·18th clinical trials on Alzheimer's disease (CTAD) conference, December 1-4, 2025, San Diego, CA (United States) - Conference proceedings - Oral communications

    Article :100617

    Plan Plan
  • ·18th Conference Clinical Trials Alzheimer’s Disease December 1-4, 2025, San Diego, CA (United States) - Conference proceedings - Posters

    Article :100618